About
PharmaCompass is a leading digital platform built to serve the global pharmaceutical industry by centralizing critical drug development and sourcing intelligence. It offers free access to a wide range of regulatory databases including US Drug Master Files (USDMFs), FDA Orange Book, Certificates of Suitability (CEPs), patents, GDUFA status, Written Confirmations, and inspection records — empowering pharma professionals to make faster, more confident decisions. Beyond regulatory data, PharmaCompass operates an integrated supplier marketplace where companies can identify and connect with manufacturers and suppliers of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The platform also aggregates pharmaceutical pricing data to help businesses benchmark and negotiate effectively. For drug development and quality teams, PharmaCompass lists a broad spectrum of contract services — spanning analytical testing (HPLC, mass spectrometry, dissolution, stability studies), bioanalytical services, container closure integrity testing, and GMP API manufacturing (including high-potency APIs, chiral synthesis, sterile injectables, lyophilization, and more). The platform is ideal for pharmaceutical manufacturers, generic drug companies, CROs, procurement teams, and regulatory affairs professionals who need centralized, reliable, and free pharma intelligence to streamline sourcing, compliance, and business development. PharmaCompass bridges the gap between pharma data and digital business growth.
Key Features
- Regulatory Database Access: Free access to USDMFs, FDA Orange Book, CEPs, GDUFA status, Written Confirmations, patents, and inspection records to support compliance and regulatory decision-making.
- API & FDF Supplier Marketplace: An integrated sourcing platform connecting pharmaceutical companies with global API and finished dosage form manufacturers and suppliers.
- Drug Pricing Intelligence: Access to pharmaceutical pricing data across APIs and FDFs, enabling procurement teams to benchmark costs and negotiate supplier contracts effectively.
- Contract Services Directory: Comprehensive listings of CRO and CDMO services including analytical testing, bioanalytical studies, GMP manufacturing, stability studies, and high-potency API production.
- Pharma News & Market Updates: Curated pharmaceutical industry news and regulatory updates to keep professionals informed on the latest market developments and policy changes.
Use Cases
- Pharmaceutical procurement teams searching for qualified API or FDF suppliers and benchmarking drug ingredient prices across global manufacturers.
- Regulatory affairs professionals verifying USDMF, CEP, FDA Orange Book, and patent status for active pharmaceutical ingredients before filing or sourcing.
- Generic drug companies conducting competitive intelligence on GDUFA status, written confirmations, and inspection records for regulatory strategy.
- CDMOs and CROs promoting their analytical, bioanalytical, or GMP manufacturing services to pharma companies actively seeking contract partners.
- Business development teams at pharma companies identifying new market opportunities, tracking competitors, and staying updated with regulatory and pricing news.
Pros
- Extensive Free Data Access: PharmaCompass provides access to a wide range of regulatory and market databases at no cost, making it highly valuable for businesses of all sizes.
- All-in-One Pharma Platform: Combines regulatory intelligence, supplier sourcing, pricing data, and service directories in a single integrated platform — eliminating the need for multiple subscriptions.
- Global Supplier Network: The marketplace connects buyers with a broad global network of API and FDF manufacturers, streamlining vendor discovery and procurement.
- Supports End-to-End Drug Development: From early-stage regulatory research through manufacturing and sourcing, PharmaCompass covers multiple stages of the pharmaceutical lifecycle.
Cons
- Pharma-Specific Scope: The platform is narrowly focused on the pharmaceutical industry and provides little value to users outside of this sector.
- Data Depth May Vary by Region: While US regulatory data (FDA, GDUFA) is well-covered, data completeness for non-US markets may vary depending on the region or regulatory body.
- Limited AI-Driven Features: The platform is primarily a data aggregator and marketplace rather than an AI-powered analytics tool, which may limit advanced analytical or predictive capabilities.
Frequently Asked Questions
Is PharmaCompass free to use?
Yes, PharmaCompass offers free access to a large portion of its regulatory databases, including USDMFs, FDA Orange Book, CEPs, patents, and pricing data. Some advanced or premium features may require registration or a paid subscription.
Who is PharmaCompass designed for?
PharmaCompass is designed for pharmaceutical manufacturers, generic drug companies, procurement and sourcing teams, regulatory affairs professionals, CROs, and CDMOs who need centralized pharmaceutical intelligence and supplier connections.
What is a USDMF and how does PharmaCompass help with it?
A US Drug Master File (USDMF) is a submission to the FDA containing confidential information about facilities, processes, or articles used in manufacturing. PharmaCompass provides searchable access to USDMF filings to help companies verify supplier regulatory standing.
Can I find API suppliers on PharmaCompass?
Yes, PharmaCompass features an integrated API and FDF supplier marketplace where you can search for and connect with manufacturers globally based on your specific compound or formulation requirements.
Does PharmaCompass provide contract manufacturing service listings?
Yes, PharmaCompass includes a comprehensive directory of contract research and manufacturing services including analytical testing, GMP API manufacturing, bioanalytical services, stability studies, and more — covering a wide range of specialized capabilities.
